Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Double Dose 4-AP on Functional Recovery After Spinal Cord Injury — Stella

Home/SCI - Spinal Cord Injury/Double Dose 4-AP on Functional Recovery After Spinal Cord Injury

View on ClinicalTrials.gov

Recruiting

Back to SCI - Spinal Cord Injury trials

Double Dose 4-AP on Functional Recovery After Spinal Cord Injury

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Shirley Ryan Abilitylab, Chicago, Illinois

Key details

Phase

Early testing / Safety & dosing

Sponsor

Shirley Ryan AbilityLab

Enrollment target

~27 participants

Started

February 2025

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 85 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.